FDA panel endorses Pfizer vaccine to speed major U S rollout
A federal advisory panel backed emergency use of Pfizer and BioNTech's COVID-19 vaccine by a 17 to 4 vote with one abstention, signaling rapid distribution amid rising cases and a race to complete safety and efficacy reviews before widespread immunization in the United States.
MENTIONED IN THIS ARTICLE
FDA
Washington
US S
Pfizer
Food and Drug Administration
Sally Goza
American Academy of Pediatrics
Britain
Paul Offit
Children’s Hospital of
Philadelphia
U.S
Peter Marks
William Moss
Johns Hopkins University
Canada
Donald Trump
White House
Stephen Hahn
Agency
Tive
Patrick Moore
University of Pittsburgh
Offit
Also Mentioned on This Page
Moderna
National Institutes of Health
Pfizer-Biontech
Johnson & Johnson
AstraZeneca
Oxford University
Ission
Pine Tree
Sun
Vjaniulece
Donrseliaeneo
Elle
Reise Mra
Wooster
St. Paul Lutheran Church
Lester Road
Valley City
Ohio
Spvc.org
the Lutheran Church— Missouri Synod
PA Lutheran Church
the Gazette
Liberty St
Medina